Cargando…
515: Pathways balancing SARS-COV-2 infectivity and disease severity in CF
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Cystic Fibrosis Society.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518441/ http://dx.doi.org/10.1016/S1569-1993(21)01939-1 |
| _version_ | 1784584223930187776 |
|---|---|
| author | Nakano, S. Okuda, K. Edwards, C. Dang, H. Asakura, T. Kato, T. Mikami, Y. Chen, G. Sun, L. Hawkins, P. Gilmore, R. Morton, L. Ribeiro, C. Pickles, R. Randell, S. O’Neal, W. Baric, R. Boucher, R. |
| author_facet | Nakano, S. Okuda, K. Edwards, C. Dang, H. Asakura, T. Kato, T. Mikami, Y. Chen, G. Sun, L. Hawkins, P. Gilmore, R. Morton, L. Ribeiro, C. Pickles, R. Randell, S. O’Neal, W. Baric, R. Boucher, R. |
| author_sort | Nakano, S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8518441 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Cystic Fibrosis Society. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85184412021-10-15 515: Pathways balancing SARS-COV-2 infectivity and disease severity in CF Nakano, S. Okuda, K. Edwards, C. Dang, H. Asakura, T. Kato, T. Mikami, Y. Chen, G. Sun, L. Hawkins, P. Gilmore, R. Morton, L. Ribeiro, C. Pickles, R. Randell, S. O’Neal, W. Baric, R. Boucher, R. J Cyst Fibros Posters European Cystic Fibrosis Society. 2021-11 2021-10-15 /pmc/articles/PMC8518441/ http://dx.doi.org/10.1016/S1569-1993(21)01939-1 Text en Copyright © 2021 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Posters Nakano, S. Okuda, K. Edwards, C. Dang, H. Asakura, T. Kato, T. Mikami, Y. Chen, G. Sun, L. Hawkins, P. Gilmore, R. Morton, L. Ribeiro, C. Pickles, R. Randell, S. O’Neal, W. Baric, R. Boucher, R. 515: Pathways balancing SARS-COV-2 infectivity and disease severity in CF |
| title | 515: Pathways balancing SARS-COV-2 infectivity and disease severity in CF |
| title_full | 515: Pathways balancing SARS-COV-2 infectivity and disease severity in CF |
| title_fullStr | 515: Pathways balancing SARS-COV-2 infectivity and disease severity in CF |
| title_full_unstemmed | 515: Pathways balancing SARS-COV-2 infectivity and disease severity in CF |
| title_short | 515: Pathways balancing SARS-COV-2 infectivity and disease severity in CF |
| title_sort | 515: pathways balancing sars-cov-2 infectivity and disease severity in cf |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518441/ http://dx.doi.org/10.1016/S1569-1993(21)01939-1 |
| work_keys_str_mv | AT nakanos 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT okudak 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT edwardsc 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT dangh 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT asakurat 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT katot 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT mikamiy 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT cheng 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT sunl 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT hawkinsp 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT gilmorer 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT mortonl 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT ribeiroc 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT picklesr 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT randells 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT onealw 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT baricr 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf AT boucherr 515pathwaysbalancingsarscov2infectivityanddiseaseseverityincf |